In conversation with Fierce Biotech’s Chris Hayden, Austin Read, head of PPD™ CorEvitas™ Precision Medicine, Thermo Fisher ...

The company's stock jumped 15% as of market close. The spike comes as the S&P 500 (SNPINDEX: ^GSPC) and the Nasdaq Composite ...

Tempus AI, Inc. (NASDAQ:TEM), a leader in artificial intelligence for healthcare, has announced the launch of Fuses, a ...

The Ibero-American Consortium gathers over 3000 DNA samples to drive precision strategies for rheumatoid arthritis and ...

In a report recently published in the American Journal of Health-System Pharmacy, the Ochsner Health system investigates the ...

The conversation centred on the company’s latest developments and strategic direction in cancer therapies, with a particular ...

Advances have made cancer therapies more effective through targeting specific molecules. Companion diagnostics (CDx) are ...

Radiopharmaceuticals are transforming modern medicine, while simultaneously intensifying the pressures on pharmaceutical ...

As National Cancer Survivors Month begins, survivors and medical professionals are highlighting the impact of personalized ...

KQ Labs has supported 70 startups, which have raised over £219 million in investment. Applications for the next program open ...

More than one quarter of the medcines cleared by the FDA’s main review office since 2015 have been cancer drugs, a tally that ...

Genetic ancestry is much more complicated than how people report their race and ethnicity. New research, using data from the ...